Ketamine clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Pragmatic Trial of Psilocybin Therapy in Palliative Care

    Sorry, not yet accepting patients

    This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).

Our lead scientists for Ketamine research studies include .

Last updated: